ArticleCurrent pharmaceutical design2024

Optimization of Hypercholesterolemia Treatment after Heart Transplant: The Role of PCSK9 Inhibitors.

Maria Jesus Valero-Masa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.